Analyst Ratings for NextCure Inc. (nxtc)
nxtc Rating Summary
nxtc Price Target Summary
- Highest: $20.00 (H.C. Wainwright)
- Lowest: $15.00 (Piper Sandler)
- Average: $17.67
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$17.67 (+42.6%)
* Over Last 12-Mos
Rating Score: 6.4 / 10
Percentile Rank: 68%
Avg. $ Target:
$17.67 (+42.6%)
* Over Last 12-Mos
Rating Score: 6.4 / 10
Percentile Rank: 68%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/7/2025 | Ladenburg Thalmann | Kevin DeGeeter | Upgrade | Buy (Neutral) |
18.00 (N/A) |
9.82 (12.39) |
26.17% | Details |
| 8/8/2023 | H.C. Wainwright » Updated 8/8/2025 |
Emily Bodnar | New Coverage | Buy (N/A) |
20.00 (3.00) |
1.70 (12.39) |
628.82% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
